表 3.
根据中国《慢性乙型肝炎防治指南(2019年版)》修改后的慢性乙型肝炎病毒感染自然病程各期特征
Characteristics of modified natural history of chronic hepatitis B virus infection in Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2019)
Clinical characteristics/immune status | Immune tolerant phase | Immune clearance phase | Immune control phase | Reactivation phase | |
a, HBeAg positive chronic infection; b, HBeAg negative chronic infection; c, severer liver injury. +, positive; -, negative. HBeAg, hepatitis B e antigen; ALT, alanine aminotransferase; HBV DNA, hepatitis B virus deoxyribonucleic acid. | |||||
Modified corresponding staging | HBeAg positive chronic HBV carrier status a | HBeAg positivechronic hepatitis | HBeAg negativechronic hepatitis | Inactive HBsAg carrier status b | HBeAg negative or positive chronic hepatitisc |
HBeAg | + | + | - | - | +/- |
ALT | Normal | Intermittently or persistently elevated | Intermittently or persistently elevated | Normal | Intermittently or persistently elevated |
Histological assessment | None/minimal inflammation and fibrosis | Moderate to severe inflammationc/fibrosis or cirrhosis | Moderate to severe inflammation/fibrosis or cirrhosisc | None/minimal inflammation and fibrosis | Moderate to severe inflammation/fibrosis or cirrhosisc |
HBV DNA | High | Moderate to high | Low | Low or undetectable | Elevated |